Name (Synonyms) | Correlation | |
---|---|---|
drug406 | Endoscopic management according to standard of care Wiki | 1.00 |
drug318 | Convalescent plasma Wiki | 0.41 |
Name (Synonyms) | Correlation | |
---|---|---|
D007565 | Jaundice, NIH | 1.00 |
D002761 | Cholangitis NIH | 1.00 |
D018281 | Cholangiocarcinoma NIH | 1.00 |
D008105 | Liver Cirrhosis, Biliary NIH | 1.00 |
D010190 | Pancreatic Neoplasms NIH | 1.00 |
D041781 | Jaundice, Obstructive NIH | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0002894 | Neoplasm of the pancreas HPO | 1.00 |
HP:0000952 | Jaundice HPO | 1.00 |
HP:0030151 | Cholangitis HPO | 1.00 |
HP:0030153 | Cholangiocarcinoma HPO | 1.00 |
There is one clinical trial.
In this study, investigators aim to explore the status of advanced endoscopy in different endoscopy units all over the world.
Description: Investigators will report the baseline demographic data (age, gender, nationality) of all patients.
Measure: Age, gender, nationality Time: 3 monthsDescription: Investigators will report the baseline data clinical data (indication for procedure, status of SARS-CoV-2 infection) of all patients.
Measure: Indication for procedure, status of SARS-CoV-2 infection Time: 3 monthsDescription: Investigators will report the baseline laboratory data (complete blood count and liver functions tests) of all patients.
Measure: Complete blood count and liver functions tests Time: 3 monthsDescription: Investigators will report the procedure related complications.
Measure: procedure related complications Time: 3 monthsDescription: Investigators will report wether the precautions lead to increase timing of the procedure
Measure: Effect of COVID-19 precautions on procedure time Time: 3 monthsDescription: Investigators will report wether the precautions affected staff number (increased or decreased)
Measure: Effect of COVID-19 precautions on staff number Time: 3 months